about
Determination of cytidine deaminase activity in synovial fluid by HPLCUrinary 8-oxo-2'-deoxyguanosine--source, significance and supplements.Disease specific biomarkers of abdominal aortic aneurysms detected by surface enhanced laser desorption ionization time of flight mass spectrometry.Hyperphosphatemia, Phosphoprotein Phosphatases, and Microparticle Release in Vascular Endothelial Cells.Biomarker research in glucose disorders: current concepts and clinical applications.A role for mitochondrial oxidants in stress-induced premature senescence of human vascular smooth muscle cells.Modulation of mitochondrial bioenergetics in a skeletal muscle cell line model of mitochondrial toxicity.Oxidative and non-oxidative DNA damage and cardiovascular disease.Immunochemical detection of UV-induced DNA damage and repair.Angiotensin II-mediated oxidative DNA damage accelerates cellular senescence in cultured human vascular smooth muscle cells via telomere-dependent and independent pathways.Immunochemical quantitation of UV-induced oxidative and dimeric DNA damage to human keratinocytes.Fibronectin and immune complexes in rheumatic diseases.Immunochemical detection of sequence-specific modifications to DNA induced by UV light.Integrated metabolic models for xenobiotic induced mitochondrial toxicity in skeletal muscle.Evidence for sensitisation of DNA to oxidative damage during isolation.32P-postlabelling approaches for the detection of 8-oxo-2'-deoxyguanosine-3'-monophosphate in DNA.Deoxycytidine glyoxal: lesion induction and evidence of repair following vitamin C supplementation in vivo.Modulation of hOGG1 DNA repair enzyme in human cultured cells in response to pro-oxidant and antioxidant challenge.Regulation of low-density lipoprotein cholesterol by intestinal inflammation and the acute phase response.Regulation of vascular function and blood pressure by circadian variation in redox signalling.Further evidence for a possible role of conformation in the immunogenicity and antigenicity of the oxidative DNA lesion, 8-oxo-2'deoxyguanosine.Blood leucocyte telomere DNA content predicts vascular telomere DNA content in humans with and without vascular disease.Vitamin C exhibits pro-oxidant properties.Novel repair action of vitamin C upon in vivo oxidative DNA damageImmunogenicity of DNA Damaged by Reactive Oxygen Species—Implications for Anti-DNA Antibodies in LupusBinding of anti-DNA antibodies to oxidatively damaged DNA in spouses and relatives of patients with systemic lupus erythematosusNucleosides and bases in synovial fluid from patients with rheumatoid arthritis and osteoarthritisApplication of a fluorimetric method for measuring DNA strand breaks in purified DNAFragmented fibronectin and other synovial fluid proteins in chronic arthritis: their relation to immune complexesQuantitative determination of cyclobutane thymine dimers in DNA by stable isotope-dilution mass spectrometry8-Hydroxydeoxyguanosine. A marker of oxidative DNA damage in systemic lupus erythematosusAnalysis of urinary pseudouridine by micellar electrokinetic capillary chromatographyImmunochemical detection of glyoxal DNA damageRapid telomere attrition in cardiac tissue of the ageing Wistar ratAutomated high-performance liquid chromatography detection of serum retinol levels in cervical cancer patients compared with normal subjectsCytochrome P450 2J2: Potential Role in Drug Metabolism and Cardiotoxicity
P50
Q28340600-DBA49E21-91F0-4A8E-BDF1-001FB645FDD5Q33892404-6D7BF334-8A5F-447F-933F-22F6B95DABABQ34272790-9CCF5A90-7822-4A80-BC7B-E8CDDF61760DQ36003122-128948BF-C399-4B8E-9546-A18FE3C1F8D4Q36988618-2FE70BC3-8A2E-4F5A-BF71-523EF40B3500Q37272651-98F356C2-2353-4CF0-9F61-65B61B6FBA9BQ37541019-279B7593-DA6B-4501-9B84-5A10FCDDFE7BQ37981208-82C20203-5BB2-45B7-A0AA-681A4D0E8237Q38350451-AB502941-6D25-4F61-BC03-2585A4A25F5CQ40275746-BDA4D8D1-ED95-4D0E-9368-2B9EC8945A40Q40850748-19765292-E9FC-4EB1-AB31-0AC8BFC92A7BQ41197943-F623ADD2-CC24-4EC9-A8FD-CFF82AF35705Q42275396-4E141879-4361-416E-A639-5C64A33FA2F1Q42282624-26D4CB25-A08A-4A23-A5A9-4C9DCE24F344Q42526611-10E9411D-18FD-491D-BEA3-2135CD555F40Q42547787-E2635568-D277-4BCE-B161-0A9A6C0DFFDBQ44274290-93AA6FB5-D9F8-483C-BCE3-37C5826B78BFQ44537863-07D7AE20-ECAC-48B6-93C0-FC04FB899FEFQ46247715-98E30FC6-1019-4C0E-9743-6FEADD6647F0Q46268060-212F88F4-0C95-451F-966B-BDB2489A1E42Q47693134-D9325E22-3189-4ECB-B564-4578FFC2C38CQ54517675-F4F8FAB7-6E2C-45D3-A417-192CFD4D35D8Q55067476-1313F84D-40F0-4538-A931-9C70F01DDA7EQ60585124-AAFCAFA9-AFFC-48D9-A82C-CC654000B32DQ60585125-2DC46376-62B6-4C0A-9AF9-193998CD4FB5Q62472842-DE8BEB0E-554F-4E6C-9217-01F9EDDB76FDQ68256354-9B9EB302-36DB-495B-A447-28B3360A978EQ68658733-9AC8C80E-3466-4CE8-8BBD-F179F81F75A8Q69416276-E6AB3D92-6635-4204-8AEE-92716C1FF97CQ71406108-8722D195-ACE0-4841-BE77-93ED73B25CC5Q72067216-B19C063F-71F3-4580-B191-7C592DC48DFFQ73688192-34E24D16-CAE1-4014-8D34-F3CC7F668CC9Q77919945-7C62DF2E-1C1D-47D3-8D46-E0FC85AB0A46Q80059144-A69F39FE-27E1-448A-B8AE-5B7B6E3D6B73Q80254547-CDF9EF90-52B5-4045-89CB-9EA5CB985995Q88475573-F251A116-52BD-4C33-893E-4AC5E54FAACE
P50
description
researcher ORCID ID = 0000-0002-6760-7929
@en
name
Karl Herbert
@ast
Karl Herbert
@en
Karl Herbert
@es
Karl Herbert
@nl
type
label
Karl Herbert
@ast
Karl Herbert
@en
Karl Herbert
@es
Karl Herbert
@nl
prefLabel
Karl Herbert
@ast
Karl Herbert
@en
Karl Herbert
@es
Karl Herbert
@nl
P1153
7006730621
P21
P31
P496
0000-0002-6760-7929